SCHEMBL19662997

SCHEMBL19662997

Cc1cccc2cc(N3CC[C@H](C)C3)ncc12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 5/20 0.47
▸ SMPD3 Q9NY59 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTR3A P46098 1/20 0.40
▸ BRD4 O60885 2/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ PDE10A Q9Y233 1/20 0.38
▸ SYK P43405 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19662984 1.00 CREBBP (0.47) CREBBPSMPD3KDM4EMAPTKMT2A
SCHEMBL23762011 1.00 CREBBP (0.47) CREBBPSMPD3KDM4EMAPTKMT2A
SCHEMBL19662787 0.87 CREBBP (0.47) CREBBPHTR3A
SCHEMBL21237243 0.84 CREBBP (0.43) CREBBPSMPD3KMT2ALMNAHTR3A
SCHEMBL21237247 0.84 CREBBP (0.43) CREBBPSMPD3KMT2ALMNAHTR3A
SCHEMBL19662775 0.84 CREBBP (0.49) CREBBPPDE10ACDK4
SCHEMBL19662788 0.84 HRH4 (0.49) —
SCHEMBL23761896 0.84 CREBBP (0.49) CREBBPPDE10ACDK4
SCHEMBL19662793 0.84 CREBBP (0.49) CREBBPPDE10ACDK4
SCHEMBL19662790 0.83 CREBBP (0.50) CREBBPHTR3APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464286-B1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2021-08-18 — — EP disclosed
WO-2017205538-A1 PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
Send feedback